RxDoctor Payments Data

Susanne Johnson

Family · Manning, SCNPI 1205069770

Payments from drug & device makers

$2,477in general payments, 2019–2025

Across 138 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$506
  • Novartis$347
  • Novo Nordisk$323
  • Lilly USA, LLC$232
  • Amgen$209
  • AbbVie$192
  • plus $667 from 14 others

What the payments were for

  • Food & beverage$2,477100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,477 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol119$103,363
JardianceEmpagliflozin108$103,295
OzempicSemaglutide69$96,047
MounjaroTirzepatide50$51,395
RybelsusSemaglutide48$48,305
EliquisApixaban62$45,886
TrulicityDulaglutide46$45,399
EntrestoSacubitril/Valsartan28$42,457
JanuviaSitagliptin Phosphate21$13,995
LinzessLinaclotide11$7,664
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$6,263
TrulancePlecanatide11$5,993
Albuterol Sulfate HfaAlbuterol Sulfate170$5,846
Colchicine52$4,921
Breo ElliptaFluticasone/Vilanterol11$4,419

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$323$144,352117 claims
AstraZenecaFarxiga, Symbicort$506$106,414132 claims
Boehringer IngelheimJardiance$133$103,295108 claims
Lilly USA, LLCMounjaro, Trulicity$232$96,79496 claims
PfizerEliquis$35$45,88662 claims
NovartisEntresto$347$42,45728 claims
AbbVieLinzess$192$7,66411 claims
GSKBreo Ellipta$22$4,41911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,248 family providers in South Carolina.

Other family in Manning

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →